Critical Therapeutics Plans Summer Submission Of Zileuton CR
This article was originally published in The Pink Sheet Daily
An NDA for the extended-release asthma therapy will use Phase III studies conducted by zileuton CR developer Abbott.
You may also be interested in...
Critical Therapeutics' controlled-release zileuton could cut the current dosing regimen for Zyflo by half, the firm said July 31
The Government Accountability Office recommends that Congress establish a bundled payment system for end-stage renal disease services - including Amgen's Epogen (epoetin) - under Medicare Part B "as soon as possible.